TTK Healthcare liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5.51×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
5.91×	5.91×	5.23×	5.50×	5.06×
5.38×	5.38×	4.72×	5.01×	4.66×
89.8	21.9	9.0	11.0	9.3
1,162	1,012	893	881	855

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

TTKHLTCARE₹1,049.10

TTK Healthcare Limited

· Others

₹ CrorePeersDCMSHRIRAM BALMLAWRIE GODREJIND 3MINDIAMcap ₹1,482 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	5.51
Current Ratio	5.06	5.50	5.23	5.91	5.91
Quick Ratio	4.66	5.01	4.72	5.38	5.38
Cash, Equiv & ST Investments	9.3	11.0	9.0	21.9	89.8
Working Capital	855.3	881.5	893.0	1,011.7	1,161.8

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.